CSST1_CONRO
ID CSST1_CONRO Reviewed; 81 AA.
AC P0DQT5;
DT 03-AUG-2022, integrated into UniProtKB/Swiss-Prot.
DT 03-AUG-2022, sequence version 1.
DT 03-AUG-2022, entry version 1.
DE RecName: Full=Consomatin Ro1 {ECO:0000303|PubMed:35319982, ECO:0000303|PubMed:35383850};
DE Short=ConSST Ro1 {ECO:0000303|PubMed:35383850};
DE AltName: Full=Somatostatin-related peptide {ECO:0000303|PubMed:35383850};
DE Short=SSRP {ECO:0000303|PubMed:35383850};
DE Flags: Precursor;
OS Conus rolani (Cone snail).
OC Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Mollusca; Gastropoda;
OC Caenogastropoda; Neogastropoda; Conoidea; Conidae; Conus; Asprella.
OX NCBI_TaxID=745791;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 58-70, FUNCTION, X-RAY
RP CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 58-70, SUBCELLULAR LOCATION, MASS
RP SPECTROMETRY, GAMMA-CARBOXYGLUTAMATION AT GLU-58, D-AMINO ACID AT TRP-64,
RP HYDROXYLATION AT PRO-69, DISULFIDE BOND, BIOASSAY, SYNTHESIS OF 58-70, AND
RP BIOTECHNOLOGY.
RC TISSUE=Venom, and Venom duct;
RX PubMed=35319982; DOI=10.1126/sciadv.abk1410;
RA Ramiro I.B.L., Bjoern-Yoshimoto W.E., Imperial J.S., Gajewiak J.,
RA Salcedo P.F., Watkins M., Taylor D., Resager W., Ueberheide B.,
RA Braeuner-Osborne H., Whitby F.G., Hill C.P., Martin L.F., Patwardhan A.,
RA Concepcion G.P., Olivera B.M., Safavi-Hemami H.;
RT "Somatostatin venom analogs evolved by fish-hunting cone snails: from prey
RT capture behavior to identifying drug leads.";
RL Sci. Adv. 8:eabk1410-eabk1410(2022).
RN [2]
RP NUCLEOTIDE SEQUENCE [MRNA].
RC TISSUE=Venom duct;
RX PubMed=35383850; DOI=10.1093/molbev/msac075;
RA Koch T.L., Ramiro I.B.L., Florez-Salcedo P., Engholm E., Jensen K.J.,
RA Chase K., Olivera B.M., Bjoern-Yoshimoto W.E., Safavi-Hemami H.;
RT "Reconstructing the origins of the somatostatin and allatostatin-C
RT signaling systems using the accelerated evolution of biodiverse cone snail
RT venoms.";
RL Mol. Biol. Evol. 0:0-0(2022).
CC -!- FUNCTION: Moderately activates human somatostatin receptors (SSTR) with
CC a preferential activation of SSTR1 (EC(50)=2.9 uM) and SSTR4
CC (EC(50)=5.1 uM). In vivo, does not cause behavioral changes in mice
CC within a few minutes of intracranial injection, but causes a
CC progressive loss of movement thereafter. Four to five hours after
CC injection, mice recover, even with the highest dose tested (5.4 mg/kg).
CC Shows antinociception and antihyperalgesia activities in two mouse
CC models of acute pain, most probably by acting outside the central
CC nervous system. {ECO:0000269|PubMed:35319982}.
CC -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:35319982}.
CC -!- TISSUE SPECIFICITY: Expressed by the venom duct.
CC {ECO:0000305|PubMed:35319982}.
CC -!- DOMAIN: The cysteine framework is C-C.
CC -!- MASS SPECTROMETRY: Mass=1573.65; Method=Electrospray;
CC Evidence={ECO:0000269|PubMed:35319982};
CC -!- BIOTECHNOLOGY: May represent a new lead for the potential development
CC of an analgesic that acts via opioid-independent pathways.
CC {ECO:0000305|PubMed:35319982}.
CC -!- MISCELLANEOUS: This peptide is an evolutionarily optimized stable
CC analog of somatostatin. In addition, it adopts nearly identical
CC conformations as in the somatostatin drug analog Octreotide. As this
CC drug, it contains a D-Trp at the same position, whose synthesis is a
CC common strategy used for enhancing the metabolic stability of compounds
CC in drug design. {ECO:0000305|PubMed:35319982}.
CC -!- MISCELLANEOUS: Consomatins evolved by gene duplication of a
CC 'Somatostatin and related peptides (SSRP)' gene expressed in the snail
CC neuroendocrine system. {ECO:0000269|PubMed:35383850}.
CC -!- MISCELLANEOUS: Does not activate any of the other 313 GPCRs tested.
CC Shows little or no activating activity at the SSTR2, SSTR3 and SSTR5.
CC {ECO:0000269|PubMed:35319982}.
CC -!- SIMILARITY: Belongs to the conotoxin C superfamily. Consomatin family.
CC {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
PE 1: Evidence at protein level;
KW D-amino acid; Direct protein sequencing; Disulfide bond;
KW G-protein coupled receptor impairing toxin; Gamma-carboxyglutamic acid;
KW Hydroxylation; Secreted; Signal; Toxin.
FT SIGNAL 1..22
FT /evidence="ECO:0000255"
FT PROPEP 23..57
FT /evidence="ECO:0000305|PubMed:35383850"
FT /id="PRO_0000456104"
FT PEPTIDE 58..70
FT /note="Consomatin Ro1"
FT /evidence="ECO:0000269|PubMed:35383850"
FT /id="PRO_0000456105"
FT PROPEP 71..81
FT /evidence="ECO:0000305|PubMed:35383850"
FT /id="PRO_0000456106"
FT MOD_RES 58
FT /note="4-carboxyglutamate"
FT /evidence="ECO:0000269|PubMed:35383850"
FT MOD_RES 64
FT /note="D-tryptophan"
FT /evidence="ECO:0000269|PubMed:35383850"
FT MOD_RES 69
FT /note="4-hydroxyproline"
FT /evidence="ECO:0000269|PubMed:35383850"
FT DISULFID 62..67
FT /evidence="ECO:0000269|PubMed:35383850"
SQ SEQUENCE 81 AA; 9461 MW; 85B1F87F71960599 CRC64;
MQTAYWVMVM MMVWITAPLS EGGKPNDVIR GLVPDDLTPQ LILRSLISRR RSDKDVREGY
KCVWKTCMPA LWRRHDLKGK D